McKesson News

McKesson Partners with Lyft to Support California Wildfire Victims

Read More

Health Mart Showcases Solutions for Clinical and Financial Performance at NCPA

Read More

McKesson RxOwnership Expands Support of Independent Pharmacy Ownership

Read More

McKesson Commits $100,000 to the American Red Cross to Support California Wildfire Victims

Read More

VERZENIO (abemaciclib) Approved for Treatment of Metastatic Breast Cancer, Available for Order at Biologics, Inc.

Read More

McKesson Corporation Fiscal 2018 Second Quarter Conference Call Scheduled for October 26, 2017

Read More

Employee Volunteers Create 15,000 Care Packages for Cancer Patients

Read More

McKesson Ventures Expands Investment Team

Read More

Health Mart Kicks-Off New ‘Revenue Remedies’ Town Hall Series

Read More

Southern Cancer Center is Global Leader in Kidney Cancer Clinical Trial

Read More

McKesson Increases Hurricane Relief Commitment to $600,000

Read More

US Oncology Research Plays an Important Role in the Clinical Development for NERLYNX™ (Neratinib) Tablets

Read More

Hurricane Irma: McKesson Prepares to Support Healthcare Providers, Pharmacies and First Responders

Read More

McKesson Commits More than $300,000 in Relief Support for Hurricane Harvey

Read More

McKesson Corporation to Present at the Morgan Stanley Global Healthcare Conference

Read More

BESPONSA (inotuzumab ozogamicin) Approved for Treatment of Adult Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia, available for order at Biologics, Inc.

Read More

Allscripts to Acquire McKesson’s Enterprise Information Solutions Business

Read More

US Oncology Research and Epizyme Establish Collaboration to Identify Non-Hodgkin Lymphoma Patients with EZH2 Mutations

Read More

Tandigm Health and Vantage Cancer Care Network Bring Value-Based Model to Oncology Care in Philadelphia

Read More

McKesson Announces Final Voting Results from 2017 Annual Meeting of Stockholders

Read More

McKesson Reports Fiscal 2018 First-Quarter Results

Read More

McKesson Declares Quarterly Dividend July 26, 2017

Read More

McKesson Announces Preliminary Voting Results from 2017 Annual Meeting of Stockholders

Read More

NERLYNX (neratinib) Tablets Approved for HER2+ Breast Cancer in the Extended Adjuvant Setting

Read More

McKesson ideaShare: Shaping the Independent’s Power to Drive Performance and Profitability

Read More

McKesson Corporation Fiscal 2018 First Quarter Conference Call Scheduled for July 27, 2017

Read More

McKesson Pharmacy Systems Unveils Key Enhancements for Its Pharmacy Management Product Lines

Read More

Mac Prescription Shop Health Mart Receives McKesson’s 2017 Pharmacy of the Year Award

Read More

McKesson Specialty Health Completes Acquisition of intraFUSION

Read More

Biologics, Inc. Earns Prestigious URAC Accreditation for Specialty Pharmacy

Read More